NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1931223940|ref|XP_037296182|]
View 

aminopeptidase N isoform X3 [Manduca sexta]

Protein Classification

M1 family metallopeptidase( domain architecture ID 10176184)

M1 family metallopeptidase containing an ERAP1-like C-terminal domain with HEAT-like repeats is a zinc-dependent metallopeptidase with an HEXXH motif as part of its active site, similar to aminopeptidase N, a broad specificity aminopeptidase, and glutamyl aminopeptidase, which releases N-terminal glutamate from a peptide

EC:  3.4.11.-
Gene Ontology:  GO:0008237|GO:0008270|GO:0006508
MEROPS:  M1

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
30-498 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


:

Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 605.73  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940  30 HYDLAFTYDIDprtNFSYYAVADIQLSVKRTTSKIVLHAQDFFIPDGKVTVSGLMDPKVLEVKLNDTFNLLTIALDKDLM 109
Cdd:cd09601     2 HYDLTLTPDLE---NFTFSGSVTITLEVLEPTDTIVLHAKDLTITSASLTLKGGSGIIEVTVVTDEETEFLTITLDETLP 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 110 EGYNYTLTIPFYGNLRQGLDGVYISSYINKKLQSKeYLIATQFEAIWARKGFPCFDEPMYKATFKVAIGHNKDFTAVANM 189
Cdd:cd09601    79 PGENYTLSIEFTGKLNDDLRGFYRSSYTDEDGETR-YLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSNM 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 190 PLMAGTnenaierhwpwmvigqtfnKDKSSFVWDYFHVSVPMSTYLVAFVVSKFSYVESPPElSHTKFRIWARSDAADQT 269
Cdd:cd09601   158 PPVEST-------------------ELEDGWKTTTFETTPPMSTYLVAFVVGDFEYIESTTK-SGVPVRVYARPGKIEQG 217
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 270 AYAANIGPRVLTHFEKWFNVSFPLPKQDMIAIPDFSAGAMENWGLITYRETALLYDKEQSSFLNKERVAEVVAHELAHQW 349
Cdd:cd09601   218 DFALEVAPKILDFYEDYFGIPYPLPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQW 297
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 350 FGNLVTMKWWSDLWLNEGFATFAASVGVAAVEPTWQALSGYAVNNILAVLNLDALESSHPVSVPIDNPKRISEIFDEISY 429
Cdd:cd09601   298 FGNLVTMKWWDDLWLNEGFATYMEYLAVDKLFPEWNMWDQFVVDELQSALELDSLASSHPIEVPVESPSEISEIFDAISY 377
                         410       420       430       440       450       460
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1931223940 430 KKGATLIRMMTMFLGDEVFRKAINRYLLKYSYKNAEQDDLWHELTMASESHgvlpRNVSVKTVMDTWTT 498
Cdd:cd09601   378 SKGASVLRMLENFLGEEVFRKGLRKYLKKHAYGNATTDDLWEALQEASGES----KPLDVKEIMDSWTL 442
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
579-910 1.22e-73

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


:

Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 245.26  E-value: 1.22e-73
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 579 WLLFNADMIAPYRVNYDARNWQLLTQALLSerySAVPVLGRVQLLSDAFALAATNRLDYTTTLKLASYLQRETDYLPLST 658
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQLLS---KVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSA 77
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 659 ALKALSKIETVLKRTPDYGAFQKYVRKLIRSSYERSGGLAVgkilNGDDLNSVKMQVMTSSWACRMKVPGCEENAVRLFN 738
Cdd:pfam11838  78 ALSQLSTLRSLLSADPEYEALKAFLRKLLSPLAEKLGWEAP----PGESHLDRQLRALLLSAACSAGDPECVAEAKKLFD 153
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 739 QWMetenpDENNPIPLDLRTAVYCAGVSRGSVREWRFVLARKQRANVAAARAQLLAALACTREVWILQQYLEWtVTDNPE 818
Cdd:pfam11838 154 AWL-----DGDDAIPPDLRWAVYCAAVANGGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALEL-ALDSDE 227
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 819 VRRQDAVSVIVNIASSSVGYYVAKEFIYTRIEEIYNAFkgHGQNSLGHIVKTLLYQFTTQRELDEFMAWhgANSKYFEDV 898
Cdd:pfam11838 228 VRNQDLRAVIAGLASNPAGRDLAWDFVKENWDALVKRL--GGGSSLGRLVKGLTPSFSTEEELDEVEAF--FADKDTPGL 303
                         330
                  ....*....|..
gi 1931223940 899 KLAVQQAIERAR 910
Cdd:pfam11838 304 RRALAQALETIR 315
 
Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
30-498 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 605.73  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940  30 HYDLAFTYDIDprtNFSYYAVADIQLSVKRTTSKIVLHAQDFFIPDGKVTVSGLMDPKVLEVKLNDTFNLLTIALDKDLM 109
Cdd:cd09601     2 HYDLTLTPDLE---NFTFSGSVTITLEVLEPTDTIVLHAKDLTITSASLTLKGGSGIIEVTVVTDEETEFLTITLDETLP 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 110 EGYNYTLTIPFYGNLRQGLDGVYISSYINKKLQSKeYLIATQFEAIWARKGFPCFDEPMYKATFKVAIGHNKDFTAVANM 189
Cdd:cd09601    79 PGENYTLSIEFTGKLNDDLRGFYRSSYTDEDGETR-YLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSNM 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 190 PLMAGTnenaierhwpwmvigqtfnKDKSSFVWDYFHVSVPMSTYLVAFVVSKFSYVESPPElSHTKFRIWARSDAADQT 269
Cdd:cd09601   158 PPVEST-------------------ELEDGWKTTTFETTPPMSTYLVAFVVGDFEYIESTTK-SGVPVRVYARPGKIEQG 217
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 270 AYAANIGPRVLTHFEKWFNVSFPLPKQDMIAIPDFSAGAMENWGLITYRETALLYDKEQSSFLNKERVAEVVAHELAHQW 349
Cdd:cd09601   218 DFALEVAPKILDFYEDYFGIPYPLPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQW 297
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 350 FGNLVTMKWWSDLWLNEGFATFAASVGVAAVEPTWQALSGYAVNNILAVLNLDALESSHPVSVPIDNPKRISEIFDEISY 429
Cdd:cd09601   298 FGNLVTMKWWDDLWLNEGFATYMEYLAVDKLFPEWNMWDQFVVDELQSALELDSLASSHPIEVPVESPSEISEIFDAISY 377
                         410       420       430       440       450       460
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1931223940 430 KKGATLIRMMTMFLGDEVFRKAINRYLLKYSYKNAEQDDLWHELTMASESHgvlpRNVSVKTVMDTWTT 498
Cdd:cd09601   378 SKGASVLRMLENFLGEEVFRKGLRKYLKKHAYGNATTDDLWEALQEASGES----KPLDVKEIMDSWTL 442
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
22-523 2.10e-115

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 367.43  E-value: 2.10e-115
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940  22 LPGDVVPRHYDLAFTYDIDPRTnfsYYAVADIQLSVKR-TTSKIVLHAQDFFIpdGKVTVSGlmdpKVLEVKLNDtfNLL 100
Cdd:COG0308    11 RPPGYDVTHYDLDLDLDPATTR---LSGTATITFTATEaPLDSLVLDLKGLEV--TSVTVDG----KPLDFTRDG--ERL 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 101 TIALDKDLMEGYNYTLTIPFYGNLRQGLDGVYISSYINKKlqskEYLIATQFEAIWARKGFPCFDEPMYKATFKVAIGHN 180
Cdd:COG0308    80 TITLPKPLAPGETFTLEIEYSGKPSNGGEGLYRSGDPPDG----PPYLYTQCEPEGARRWFPCFDHPDDKATFTLTVTVP 155
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 181 KDFTAVANMPLMAgTNENAIERHWpwmvigqtfnkdkssfvwDYFHVSVPMSTYLVAFVVSKFSYVESPPElSHTKFRIW 260
Cdd:COG0308   156 AGWVAVSNGNLVS-ETELGDGRTT------------------WHWADTQPIPTYLFALAAGDYAVVEDTFA-SGVPLRVY 215
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 261 ARSDAADQTAYAANIGPRVLTHFEKWFNVSFPLPKQDMIAIPDFSAGAMENWGLITYRETALLYDKEQSSflNKERVAEV 340
Cdd:COG0308   216 VRPGLADKAKEAFESTKRMLDFFEELFGVPYPFDKYDQVAVPDFNFGAMENQGLVTFGEKVLADETATDA--DYERRESV 293
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 341 VAHELAHQWFGNLVTMKWWSDLWLNEGFATFAASVGVAAVEPtWQALSGYAVNNILAV-LNLDALESSHPVSvpIDNPKR 419
Cdd:COG0308   294 IAHELAHQWFGNLVTCADWDDLWLNEGFATYMEQLFSEDLYG-KDAADRIFVGALRSYaFAEDAGPNAHPIR--PDDYPE 370
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 420 ISEIFDEISYKKGATLIRMMTMFLGDEVFRKAINRYLLKYSYKNAEQDDLWHELTMASeshgvlprNVSVKTVMDTWTTQ 499
Cdd:COG0308   371 IENFFDGIVYEKGALVLHMLRTLLGDEAFRAGLRLYFARHAGGNATTEDFLAALEEAS--------GRDLSAFFDQWLYQ 442
                         490       500
                  ....*....|....*....|....*..
gi 1931223940 500 TGYPLLTVTRDYDDQ---SVTVTQRRY 523
Cdd:COG0308   443 AGLPTLEVEYEYDADgkvTLTLRQTPP 469
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
271-496 2.54e-96

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 302.67  E-value: 2.54e-96
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 271 YAANIGPRVLTHFEKWFNVSFPLPKQDMIAIPDFSAGAMENWGLITYRETALLYDKEQSSFLNKERVAEVVAHELAHQWF 350
Cdd:pfam01433   1 YALEITVKLLEFYEDYFNIPYPLPKYDLVALPDFSAGAMENWGLITYRETLLLYDPGNSSTSDKQRVASVIAHELAHQWF 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 351 GNLVTMKWWSDLWLNEGFATFAASVGVAAVEPTWQALSGYAVNNILAVLNLDALESSHPVSVPIDNPKRISEIFDEISYK 430
Cdd:pfam01433  81 GNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIWEQFLLDEVQNAMARDALDSSHPITQNVNDPSEIDDIFDAIPYE 160
                         170       180       190       200       210       220
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1931223940 431 KGATLIRMMTMFLGDEVFRKAINRYLLKYSYKNAEQDDLWHELTMASEShgvlprnVSVKTVMDTW 496
Cdd:pfam01433 161 KGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDALSEASGP-------LDVDSFMDTW 219
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
579-910 1.22e-73

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 245.26  E-value: 1.22e-73
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 579 WLLFNADMIAPYRVNYDARNWQLLTQALLSerySAVPVLGRVQLLSDAFALAATNRLDYTTTLKLASYLQRETDYLPLST 658
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQLLS---KVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSA 77
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 659 ALKALSKIETVLKRTPDYGAFQKYVRKLIRSSYERSGGLAVgkilNGDDLNSVKMQVMTSSWACRMKVPGCEENAVRLFN 738
Cdd:pfam11838  78 ALSQLSTLRSLLSADPEYEALKAFLRKLLSPLAEKLGWEAP----PGESHLDRQLRALLLSAACSAGDPECVAEAKKLFD 153
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 739 QWMetenpDENNPIPLDLRTAVYCAGVSRGSVREWRFVLARKQRANVAAARAQLLAALACTREVWILQQYLEWtVTDNPE 818
Cdd:pfam11838 154 AWL-----DGDDAIPPDLRWAVYCAAVANGGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALEL-ALDSDE 227
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 819 VRRQDAVSVIVNIASSSVGYYVAKEFIYTRIEEIYNAFkgHGQNSLGHIVKTLLYQFTTQRELDEFMAWhgANSKYFEDV 898
Cdd:pfam11838 228 VRNQDLRAVIAGLASNPAGRDLAWDFVKENWDALVKRL--GGGSSLGRLVKGLTPSFSTEEELDEVEAF--FADKDTPGL 303
                         330
                  ....*....|..
gi 1931223940 899 KLAVQQAIERAR 910
Cdd:pfam11838 304 RRALAQALETIR 315
pepN_strep_liv TIGR02412
aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the ...
150-513 9.08e-62

aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the zinc metallopeptidase family M1 (pfam01433), with a single member characterized in Streptomyces lividans 66 and designated aminopeptidase N. The spectrum of activity may differ somewhat from the aminopeptidase N clade of E. coli and most other Proteobacteria, well separated phylogenetically within the M1 family. The M1 family also includes leukotriene A-4 hydrolase/aminopeptidase (with a bifunctional active site).


Pssm-ID: 274121 [Multi-domain]  Cd Length: 831  Bit Score: 225.82  E-value: 9.08e-62
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 150 TQFEAIWARKGFPCFDEPMYKATFKVAIGHNKDFTAVANMPLMAGTNENAierhwpwmvigqtFNkdkssfVWDyFHVSV 229
Cdd:TIGR02412 122 TQFEPADARRVFAVFDQPDLKANFKFSVKAPEDWTVISNSRETDVTPEPA-------------DR------RWE-FPETP 181
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 230 PMSTYLVAFVVSkfSYVESPPELSHTKFRIWARSDAADQTAYAA--NIGPRVLTHFEKWFNVSFPLPKQDMIAIPDFSAG 307
Cdd:TIGR02412 182 KLSTYLTAVAAG--PYHSVQDESRSYPLGIYARRSLAQYLDADAifTITRQGLAFFHRKFGYPYPFKKYDQIFVPEFNAG 259
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 308 AMENWGLITYRETALLYDKEQSSflNKERVAEVVAHELAHQWFGNLVTMKWWSDLWLNEGFATFAASVGVAAVEPTWQAL 387
Cdd:TIGR02412 260 AMENAGCVTFAENFLHRAEATRA--EKENRAGVILHEMAHMWFGDLVTMRWWNDLWLNESFAEYMGTLASAEATEYTDAW 337
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 388 SGYAVNNILAVLNLDALESSHPVSVPIDNPKRISEIFDEISYKKGATLIRMMTMFLGDEVFRKAINRYLLKYSYKNAEQD 467
Cdd:TIGR02412 338 TTFAAQGKQWAYEADQLPTTHPIVADVADLADALSNFDGITYAKGASVLKQLVAWVGEEAFFAGVNAYFKRHAFGNATLD 417
                         330       340       350       360
                  ....*....|....*....|....*....|....*....|....*.
gi 1931223940 468 DLWHELTMASEshgvlpRNVSVKTvmDTWTTQTGYPLLTVTRDYDD 513
Cdd:TIGR02412 418 DLIDSLAKASG------RDLSAWS--DAWLETAGVNTLTPEITTDG 455
pepN PRK14015
aminopeptidase N; Provisional
298-521 3.88e-13

aminopeptidase N; Provisional


Pssm-ID: 237585 [Multi-domain]  Cd Length: 875  Bit Score: 73.63  E-value: 3.88e-13
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 298 MI-AIPDFSAGAMENWGL-I---TY----RETALlyDKEqssFLNKERVaevVAHELAHQWFGNLVTMKWWSDLWLNEGF 368
Cdd:PRK14015  256 MIvAVDDFNMGAMENKGLnIfnsKYvladPETAT--DAD---YERIESV---IAHEYFHNWTGNRVTCRDWFQLSLKEGL 327
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 369 -----ATFAASVGVAAVeptwqalsgyavNNILAVLNL-------DALESSHPVsVPidnpkrisEIFDEIS-------Y 429
Cdd:PRK14015  328 tvfrdQEFSADLGSRAV------------KRIEDVRVLraaqfaeDAGPMAHPV-RP--------DSYIEINnfytatvY 386
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 430 KKGATLIRMMTMFLGDEVFRKAINRYLLKYSYKNAEQDDLWHelTMASEShGVlprnvsvktvmD-----TWTTQTGYPL 504
Cdd:PRK14015  387 EKGAEVIRMLHTLLGEEGFRKGMDLYFERHDGQAVTCEDFVA--AMEDAS-GR-----------DlsqfrRWYSQAGTPR 452
                         250       260
                  ....*....|....*....|.
gi 1931223940 505 LTVTRDYDDQS----VTVTQR 521
Cdd:PRK14015  453 VTVSDEYDAAAgtytLTLSQS 473
 
Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
30-498 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 605.73  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940  30 HYDLAFTYDIDprtNFSYYAVADIQLSVKRTTSKIVLHAQDFFIPDGKVTVSGLMDPKVLEVKLNDTFNLLTIALDKDLM 109
Cdd:cd09601     2 HYDLTLTPDLE---NFTFSGSVTITLEVLEPTDTIVLHAKDLTITSASLTLKGGSGIIEVTVVTDEETEFLTITLDETLP 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 110 EGYNYTLTIPFYGNLRQGLDGVYISSYINKKLQSKeYLIATQFEAIWARKGFPCFDEPMYKATFKVAIGHNKDFTAVANM 189
Cdd:cd09601    79 PGENYTLSIEFTGKLNDDLRGFYRSSYTDEDGETR-YLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSNM 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 190 PLMAGTnenaierhwpwmvigqtfnKDKSSFVWDYFHVSVPMSTYLVAFVVSKFSYVESPPElSHTKFRIWARSDAADQT 269
Cdd:cd09601   158 PPVEST-------------------ELEDGWKTTTFETTPPMSTYLVAFVVGDFEYIESTTK-SGVPVRVYARPGKIEQG 217
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 270 AYAANIGPRVLTHFEKWFNVSFPLPKQDMIAIPDFSAGAMENWGLITYRETALLYDKEQSSFLNKERVAEVVAHELAHQW 349
Cdd:cd09601   218 DFALEVAPKILDFYEDYFGIPYPLPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQW 297
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 350 FGNLVTMKWWSDLWLNEGFATFAASVGVAAVEPTWQALSGYAVNNILAVLNLDALESSHPVSVPIDNPKRISEIFDEISY 429
Cdd:cd09601   298 FGNLVTMKWWDDLWLNEGFATYMEYLAVDKLFPEWNMWDQFVVDELQSALELDSLASSHPIEVPVESPSEISEIFDAISY 377
                         410       420       430       440       450       460
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1931223940 430 KKGATLIRMMTMFLGDEVFRKAINRYLLKYSYKNAEQDDLWHELTMASESHgvlpRNVSVKTVMDTWTT 498
Cdd:cd09601   378 SKGASVLRMLENFLGEEVFRKGLRKYLKKHAYGNATTDDLWEALQEASGES----KPLDVKEIMDSWTL 442
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
22-523 2.10e-115

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 367.43  E-value: 2.10e-115
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940  22 LPGDVVPRHYDLAFTYDIDPRTnfsYYAVADIQLSVKR-TTSKIVLHAQDFFIpdGKVTVSGlmdpKVLEVKLNDtfNLL 100
Cdd:COG0308    11 RPPGYDVTHYDLDLDLDPATTR---LSGTATITFTATEaPLDSLVLDLKGLEV--TSVTVDG----KPLDFTRDG--ERL 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 101 TIALDKDLMEGYNYTLTIPFYGNLRQGLDGVYISSYINKKlqskEYLIATQFEAIWARKGFPCFDEPMYKATFKVAIGHN 180
Cdd:COG0308    80 TITLPKPLAPGETFTLEIEYSGKPSNGGEGLYRSGDPPDG----PPYLYTQCEPEGARRWFPCFDHPDDKATFTLTVTVP 155
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 181 KDFTAVANMPLMAgTNENAIERHWpwmvigqtfnkdkssfvwDYFHVSVPMSTYLVAFVVSKFSYVESPPElSHTKFRIW 260
Cdd:COG0308   156 AGWVAVSNGNLVS-ETELGDGRTT------------------WHWADTQPIPTYLFALAAGDYAVVEDTFA-SGVPLRVY 215
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 261 ARSDAADQTAYAANIGPRVLTHFEKWFNVSFPLPKQDMIAIPDFSAGAMENWGLITYRETALLYDKEQSSflNKERVAEV 340
Cdd:COG0308   216 VRPGLADKAKEAFESTKRMLDFFEELFGVPYPFDKYDQVAVPDFNFGAMENQGLVTFGEKVLADETATDA--DYERRESV 293
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 341 VAHELAHQWFGNLVTMKWWSDLWLNEGFATFAASVGVAAVEPtWQALSGYAVNNILAV-LNLDALESSHPVSvpIDNPKR 419
Cdd:COG0308   294 IAHELAHQWFGNLVTCADWDDLWLNEGFATYMEQLFSEDLYG-KDAADRIFVGALRSYaFAEDAGPNAHPIR--PDDYPE 370
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 420 ISEIFDEISYKKGATLIRMMTMFLGDEVFRKAINRYLLKYSYKNAEQDDLWHELTMASeshgvlprNVSVKTVMDTWTTQ 499
Cdd:COG0308   371 IENFFDGIVYEKGALVLHMLRTLLGDEAFRAGLRLYFARHAGGNATTEDFLAALEEAS--------GRDLSAFFDQWLYQ 442
                         490       500
                  ....*....|....*....|....*..
gi 1931223940 500 TGYPLLTVTRDYDDQ---SVTVTQRRY 523
Cdd:COG0308   443 AGLPTLEVEYEYDADgkvTLTLRQTPP 469
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
271-496 2.54e-96

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 302.67  E-value: 2.54e-96
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 271 YAANIGPRVLTHFEKWFNVSFPLPKQDMIAIPDFSAGAMENWGLITYRETALLYDKEQSSFLNKERVAEVVAHELAHQWF 350
Cdd:pfam01433   1 YALEITVKLLEFYEDYFNIPYPLPKYDLVALPDFSAGAMENWGLITYRETLLLYDPGNSSTSDKQRVASVIAHELAHQWF 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 351 GNLVTMKWWSDLWLNEGFATFAASVGVAAVEPTWQALSGYAVNNILAVLNLDALESSHPVSVPIDNPKRISEIFDEISYK 430
Cdd:pfam01433  81 GNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIWEQFLLDEVQNAMARDALDSSHPITQNVNDPSEIDDIFDAIPYE 160
                         170       180       190       200       210       220
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1931223940 431 KGATLIRMMTMFLGDEVFRKAINRYLLKYSYKNAEQDDLWHELTMASEShgvlprnVSVKTVMDTW 496
Cdd:pfam01433 161 KGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDALSEASGP-------LDVDSFMDTW 219
M1_APN cd09602
Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the ...
30-478 2.18e-88

Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the catalytic domain of bacterial and eukaryotic aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341065 [Multi-domain]  Cd Length: 440  Bit Score: 289.80  E-value: 2.18e-88
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940  30 HYDLAFTYDIDPRTnfsYYAVADIQLSVKRTTSKIVLhaqDFFipdgkvtvsglmDPKVLEVKLNDT------FNLLTIA 103
Cdd:cd09602    17 SYDLDLDLTEGAET---FRGTVTIRFTLREPGASLFL---DFR------------GGEVKSVTLNGRpldpsaFDGERIT 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 104 LDKDLMEGYNyTLTIPF---YGNLRQGLDgvyisSYINKKlQSKEYLIaTQFEAIWARKGFPCFDEPMYKATFKVAIGHN 180
Cdd:cd09602    79 LPGLLKAGEN-TVVVEFtapYSSDGEGLH-----RFVDPA-DGETYLY-TLFEPDDARRVFPCFDQPDLKATFTLTVTAP 150
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 181 KDFTAVANMPLmAGTNENAIERHWpwmvigqtfnkdkssfvwdYFHVSVPMSTYLVAFVVSKFSYVESppELSHTKFRIW 260
Cdd:cd09602   151 ADWTVISNGPE-TSTEEAGGRKRW-------------------RFAETPPLSTYLFAFVAGPYHRVED--EHDGIPLGLY 208
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 261 AR-SDAA---------DQTAYAanigprvLTHFEKWFNVSFPLPKQDMIAIPDFSAGAMENWGLITYRETALLYdkEQSS 330
Cdd:cd09602   209 CReSLAEyerdadeifEVTKQG-------LDFYEDYFGIPYPFGKYDQVFVPEFNFGAMENPGAVTFRESYLFR--EEPT 279
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 331 FLNKERVAEVVAHELAHQWFGNLVTMKWWSDLWLNEGFATFAASVGVAAVEPTWQALSGYAVNNILAVLNLDALESSHPV 410
Cdd:cd09602   280 RAQRLRRANTILHEMAHMWFGDLVTMKWWDDLWLNESFADFMAAKALAEATPFTDAWLTFLLRRKPWAYRADQLPTTHPI 359
                         410       420       430       440       450       460
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1931223940 411 SVPIDNPKRISEIFDEISYKKGATLIRMMTMFLGDEVFRKAINRYLLKYSYKNAEQDDLWHELTMASE 478
Cdd:cd09602   360 AQDVPDLEAAGSNFDGITYAKGASVLKQLVALVGEEAFRAGLREYFKKHAYGNATLDDLIAALDEASG 427
M1 cd09595
Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 ...
30-470 8.96e-88

Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 hydrolase; The model represents the catalytic domains of M1 peptidase family members including aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). All peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile upon activation during catalysis. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. APN expression is dysregulated in many inflammatory diseases and is enhanced in numerous tumor cells, making it a lead target in the development of anti-cancer and anti-inflammatory drugs. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase in LTA4H is as yet unknown, while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals.


Pssm-ID: 341058 [Multi-domain]  Cd Length: 413  Bit Score: 287.03  E-value: 8.96e-88
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940  30 HYDLAFTYDIDPRTnFSYYAVADIQLSvkRTTSKIVLHAQDFFIpdGKVTVSGLmdpKVLEVKLNDTFN-LLTIALDKdl 108
Cdd:cd09595     2 HYDLDLDVDFTTKT-LNGTETLTVDAS--QVGRELVLDLVGLTI--HSVSVNGA---AVDFGEREHYDGeKLTIPGPK-- 71
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 109 MEGYNYTLTIPFYGNLRQGLDGVYISSYINKKlqskEYLIATQFEAIWARKGFPCFDEPMYKATFKVAIGHNKDFTaVAN 188
Cdd:cd09595    72 PPGQTFTVRISFEAKPSKNLLGWLWEQTAGKE----KPYLFTQFEATHARRIFPCIDHPAVKATFTVTITTPKKDL-LAS 146
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 189 MPLMAGTNENAIERHWpwmvigqtfnkdkssfvwDYFHVSVPMSTYLVAFVVSKFSY-VESPPELSHTKFRIWARSDAAD 267
Cdd:cd09595   147 NGALVGEETGANGRKT------------------YRFEDTPPIPTYLVAVVVGDLEFkYVTVKSQPRVGLSVYSEPLQVD 208
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 268 QTAYAANIGPRVLTHFEKWFNVSFPLPKQDMIAIPDFSAGAMENWGLITYRETALLYDKEQSSflNKERVAEVVAHELAH 347
Cdd:cd09595   209 QAQYAFDATRAALAWFEDYFGGPYPLPKYDLLAVPDFNSGAMENPGLITFRTTYLLRSKVTDT--GARSIENVIAHELAH 286
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 348 QWFGNLVTMKWWSDLWLNEGFATFAASVGVAAVEPTW----QALSGYAVNNilavlNLDALESSHPVSVPIDNPKRISEI 423
Cdd:cd09595   287 QWFGNLVTMRWWNDLWLNEGFAVYYENRIMDATFGTSsrhlDQLSGSSDLN-----TEQLLEDSSPTSTPVRSPADPDVA 361
                         410       420       430       440
                  ....*....|....*....|....*....|....*....|....*..
gi 1931223940 424 FDEISYKKGATLIRMMTMFLGDEVFRKAINRYLLKYSYKNAEQDDLW 470
Cdd:cd09595   362 YDGVTYAKGALVLRMLEELVGEEAFDKGVQAYFNRHKFKNATTDDFI 408
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
579-910 1.22e-73

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 245.26  E-value: 1.22e-73
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 579 WLLFNADMIAPYRVNYDARNWQLLTQALLSerySAVPVLGRVQLLSDAFALAATNRLDYTTTLKLASYLQRETDYLPLST 658
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQLLS---KVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSA 77
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 659 ALKALSKIETVLKRTPDYGAFQKYVRKLIRSSYERSGGLAVgkilNGDDLNSVKMQVMTSSWACRMKVPGCEENAVRLFN 738
Cdd:pfam11838  78 ALSQLSTLRSLLSADPEYEALKAFLRKLLSPLAEKLGWEAP----PGESHLDRQLRALLLSAACSAGDPECVAEAKKLFD 153
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 739 QWMetenpDENNPIPLDLRTAVYCAGVSRGSVREWRFVLARKQRANVAAARAQLLAALACTREVWILQQYLEWtVTDNPE 818
Cdd:pfam11838 154 AWL-----DGDDAIPPDLRWAVYCAAVANGGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALEL-ALDSDE 227
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 819 VRRQDAVSVIVNIASSSVGYYVAKEFIYTRIEEIYNAFkgHGQNSLGHIVKTLLYQFTTQRELDEFMAWhgANSKYFEDV 898
Cdd:pfam11838 228 VRNQDLRAVIAGLASNPAGRDLAWDFVKENWDALVKRL--GGGSSLGRLVKGLTPSFSTEEELDEVEAF--FADKDTPGL 303
                         330
                  ....*....|..
gi 1931223940 899 KLAVQQAIERAR 910
Cdd:pfam11838 304 RRALAQALETIR 315
pepN_strep_liv TIGR02412
aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the ...
150-513 9.08e-62

aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the zinc metallopeptidase family M1 (pfam01433), with a single member characterized in Streptomyces lividans 66 and designated aminopeptidase N. The spectrum of activity may differ somewhat from the aminopeptidase N clade of E. coli and most other Proteobacteria, well separated phylogenetically within the M1 family. The M1 family also includes leukotriene A-4 hydrolase/aminopeptidase (with a bifunctional active site).


Pssm-ID: 274121 [Multi-domain]  Cd Length: 831  Bit Score: 225.82  E-value: 9.08e-62
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 150 TQFEAIWARKGFPCFDEPMYKATFKVAIGHNKDFTAVANMPLMAGTNENAierhwpwmvigqtFNkdkssfVWDyFHVSV 229
Cdd:TIGR02412 122 TQFEPADARRVFAVFDQPDLKANFKFSVKAPEDWTVISNSRETDVTPEPA-------------DR------RWE-FPETP 181
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 230 PMSTYLVAFVVSkfSYVESPPELSHTKFRIWARSDAADQTAYAA--NIGPRVLTHFEKWFNVSFPLPKQDMIAIPDFSAG 307
Cdd:TIGR02412 182 KLSTYLTAVAAG--PYHSVQDESRSYPLGIYARRSLAQYLDADAifTITRQGLAFFHRKFGYPYPFKKYDQIFVPEFNAG 259
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 308 AMENWGLITYRETALLYDKEQSSflNKERVAEVVAHELAHQWFGNLVTMKWWSDLWLNEGFATFAASVGVAAVEPTWQAL 387
Cdd:TIGR02412 260 AMENAGCVTFAENFLHRAEATRA--EKENRAGVILHEMAHMWFGDLVTMRWWNDLWLNESFAEYMGTLASAEATEYTDAW 337
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 388 SGYAVNNILAVLNLDALESSHPVSVPIDNPKRISEIFDEISYKKGATLIRMMTMFLGDEVFRKAINRYLLKYSYKNAEQD 467
Cdd:TIGR02412 338 TTFAAQGKQWAYEADQLPTTHPIVADVADLADALSNFDGITYAKGASVLKQLVAWVGEEAFFAGVNAYFKRHAFGNATLD 417
                         330       340       350       360
                  ....*....|....*....|....*....|....*....|....*.
gi 1931223940 468 DLWHELTMASEshgvlpRNVSVKTvmDTWTTQTGYPLLTVTRDYDD 513
Cdd:TIGR02412 418 DLIDSLAKASG------RDLSAWS--DAWLETAGVNTLTPEITTDG 455
M1_APN_like cd09603
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly ...
25-469 2.81e-59

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly bacterial and some archaeal M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341066 [Multi-domain]  Cd Length: 410  Bit Score: 208.98  E-value: 2.81e-59
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940  25 DVvpRHYDLAFTYDIDPRtnfSYYAVADIQLSVKRTTSKIVLHAQDFFIpdGKVTVSGlmdpkVLEVKLNDTFNLLTIAL 104
Cdd:cd09603     2 DV--LHYDLDLDYDPATK---SLSGTATITFRATQDLDSLQLDLVGLTV--SSVTVDG-----VPAAFFTHDGDKLVITL 69
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 105 DKDLMEGYNYTLTIPFYGNLRQGLDGVY-ISSYINKKLQskeylIATQFEAIWARKGFPCFDEPMYKATFKVAIGHNKDF 183
Cdd:cd09603    70 PRPLAAGETFTVTVRYSGKPRPAGYPPGdGGGWEEGDDG-----VWTAGQPEGASTWFPCNDHPDDKATYDITVTVPAGL 144
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 184 TAVANmplmaGTnenaierhwpwmVIGQTFNKD-KSSFVWdyfHVSVPMSTYLVAFVVSKFSyVESPPELSHTKFRIWAR 262
Cdd:cd09603   145 TVVSN-----GR------------LVSTTTNGGgTTTWHW---KMDYPIATYLVTLAVGRYA-VVEDGSGGGIPLRYYVP 203
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 263 SDAADQTAYAANIGPRVLTHFEKWFnVSFPLPKQDMIAIPDFSaGAMENWGLITYRETALLYDKEQSSflnkervaeVVA 342
Cdd:cd09603   204 PGDAAKAKASFARTPEMLDFFEELF-GPYPFEKYGQVVVPDLG-GGMEHQTATTYGNNFLNGDRGSER---------LIA 272
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 343 HELAHQWFGNLVTMKWWSDLWLNEGFATFAASVGVAAVEPTwQALSGYAVNNILAVLNLDAlesshpvsvPIDNPKRISE 422
Cdd:cd09603   273 HELAHQWFGDSVTCADWADIWLNEGFATYAEWLWSEHKGGA-DAYRAYLAGQRQDYLNADP---------GPGRPPDPDD 342
                         410       420       430       440
                  ....*....|....*....|....*....|....*....|....*..
gi 1931223940 423 IFDEISYKKGATLIRMMTMFLGDEVFRKAINRYLLKYSYKNAEQDDL 469
Cdd:cd09603   343 LFDRDVYQKGALVLHMLRNLLGDEAFFAALRAYLARYAHGNVTTEDF 389
Peptidase_M1_N pfam17900
Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from ...
27-235 9.09e-40

Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from the M1 family.


Pssm-ID: 465557 [Multi-domain]  Cd Length: 186  Bit Score: 145.57  E-value: 9.09e-40
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940  27 VPRHYDLafTYDIDPrTNFSYYAVADIQLSVKRTTSKIVLHAQDFFIPDGKVTVSGLMDPKVLEVKLND-TFNLLTIALD 105
Cdd:pfam17900   1 VPEHYDL--DLKIDL-KNFTFSGSVTITLQLNNATNVIVLHASDLTIRSISLSDEVTSDGVPADFTEDQkDGEKLTIVLP 77
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 106 KDLMEGYNYTLTIPFYGNLRQGLDGVYISSYINKKlqSKEYLIATQFEAIWARKGFPCFDEPMYKATFKVAIGHNKDFTA 185
Cdd:pfam17900  78 ETLNQTGPYTLEIEYSGELNDSMTGFYRSTYTDNG--EKKVLVTTQFEPTDARSAFPCFDEPSVKATFTISIIHPKDYTA 155
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|
gi 1931223940 186 VANMPlmagtnenaierhwpwmVIGQTfnKDKSSFVWDYFHVSVPMSTYL 235
Cdd:pfam17900 156 LSNMP-----------------VIASE--PLENGWVITTFEQTPKMSTYL 186
M1_LTA4H cd09599
Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents ...
23-462 7.54e-28

Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents the N-terminal catalytic domain of leukotriene A4 hydrolase (LTA4H; E.C. 3.3.2.6) and the close homolog cold-active aminopeptidase (Colwellia psychrerythraea-type peptidase; ColAP), both members of the aminopeptidase M1 family. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase is poorly understood while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals. It accepts a variety of substrates, including some opioid, di- and tripeptides, as well as chromogenic aminoacyl-p-nitroanilide derivatives. The aminopeptidase activity of LTA4H is possibly involved in the processing of peptides related to inflammation and host defense. Kinetic analysis shows that LTA4H hydrolyzes arginyl tripeptides with high efficiency and specificity, indicating its function as an arginyl aminopeptidase. Thermodynamic characterization using different biophysical methods shows that structurally distinct inhibitors of the LTA4H occupy different regions of the binding site; while some (RB202, ARM1 and SC57461A) bind to the hydrophobic hydrolase side, both bestatin and captopril are located at the hydrophilic peptidase side. LTB4H overexpression is associated with different pathological conditions and diseases such as cystic fibrosis, coronary heart disease, sepsis, shock, connective tissue disease, and chronic obstructive pulmonary disease. It is also overexpressed in certain human cancers, and has been identified as a functionally important target for mediating anticancer properties of resveratrol, a well-known red wine polyphenolic compound with cancer chemopreventive activity.


Pssm-ID: 341062 [Multi-domain]  Cd Length: 442  Bit Score: 117.94  E-value: 7.54e-28
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940  23 PGDVVPRHYDLAFTYDIDPRTnfsYYAVADIQLSVKRT-TSKIVLHAQDFFIpdGKVTVSGlmdPKVLEVKLNDTFNL-- 99
Cdd:cd09599     8 YDEVRTTHLDLDLTVDFDKKT---ISGSATLTLEVLQDgADELVLDTRDLDI--SSVTVNG---GKELKFELGPRDPVlg 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 100 --LTIALDKDLMEGYNYTLTIpfygnlrqgldgVYISSYINKKLQ--SKE--------YLIaTQFEAIWARKGFPCFDEP 167
Cdd:cd09599    80 saLTITLPSPLAKGDTFKVKI------------EYSTTPQATALQwlTPEqtagkkhpYLF-TQCQAIHARSLFPCQDTP 146
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 168 MYKATFKVAIGHNKDFTAvanmpLMAGTNenaierhwpwmvIGQTFNKDKSSFvwdYFHVSVPMSTYLVAFVV------- 240
Cdd:cd09599   147 SVKSTYSATVTVPKGLTA-----LMSALR------------TGEKEEAGTGTY---TFEQPVPIPSYLIAIAVgdlesre 206
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 241 -SKFSYVESPPEL---SHTKFriwarSDAADQTAYAAN-IGPRVlthfekW--FNV-----SFPLpkqdmiaipdfsaGA 308
Cdd:cd09599   207 iGPRSGVWAEPSVvdaAAEEF-----ADTEKFLKAAEKlYGPYV------WgrYDLlvlppSFPY-------------GG 262
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 309 MENWGLITYRETALLYDKEQSSflnkervaeVVAHELAHQWFGNLVTMKWWSDLWLNEGFATFAASVGVAAVEptwqals 388
Cdd:cd09599   263 MENPCLTFATPTLIAGDRSLVD---------VIAHEIAHSWSGNLVTNANWEHFWLNEGFTVYLERRILERLY------- 326
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 389 GYAVNNILAVLNLDALESS-------HP-VSVPID----NPkriSEIFDEISYKKGATLIRMMTMFLGDEVFRKAINRYL 456
Cdd:cd09599   327 GEEYRQFEAILGWKDLQESikefgedPPyTLLVPDlkgvDP---DDAFSSVPYEKGFQFLYYLEQLGGREVFDPFLRAYF 403

                  ....*.
gi 1931223940 457 LKYSYK 462
Cdd:cd09599   404 KKFAFQ 409
leuko_A4_hydro TIGR02411
leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive ...
19-473 2.60e-25

leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive subset within the zinc metallopeptidase family M1 (pfam01433). The majority of the members of pfam01433 are aminopeptidases, but the sequences in this family for which the function is known are leukotriene A-4 hydrolase. A dual epoxide hydrolase and aminopeptidase activity at the same active site is indicated. The physiological substrate for aminopeptidase activity is not known.


Pssm-ID: 274120 [Multi-domain]  Cd Length: 602  Bit Score: 112.18  E-value: 2.60e-25
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940  19 SYLLPGDVVPRHYDLAFTYDIDPRTnfsYYAVADIQLSVKR-TTSKIVLHAQDFFIPdgKVTVSGLMDPKVLEVKLNDTF 97
Cdd:TIGR02411   4 SLSNYKDFRTSHTDLNLSVDFTKRK---LSGSVTFTLKSLTdNLNKLVLDTSYLDIQ--KVTINGLPADFAIGERKEPLG 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940  98 NLLTIALDKDLMEGYNYTLTIPFygnlrQGLDGVYISSYINKKL---QSKEYLIaTQFEAIWARKGFPCFDEPMYKATFK 174
Cdd:TIGR02411  79 SPLTISLPIATSKNDEFVLNISF-----STTPKCTALQWLNPEQtsgKKHPYLF-SQCQAIHARSLFPCQDTPSVKSTYT 152
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 175 VAIGHnkDFTAvanmpLMAGtnenaierhwpwmVIGQTFNKDKSSFVwdyFHVSVPMSTYLVAFVVSKFSyvesppelsh 254
Cdd:TIGR02411 153 AEVES--PLPV-----LMSG-------------IRDGETSNDPGKYL---FKQKVPIPAYLIAIASGDLA---------- 199
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 255 tkfriwarsdaadqtayAANIGPRVLTHFEKwFNVS-----FPLPKQDMIAI-------------------PDFSAGAME 310
Cdd:TIGR02411 200 -----------------SAPIGPRSTVYSEP-EQLEkcqyeFENDTEKFIKTaedlifpyewgqydllvlpPSFPYGGME 261
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 311 NWGLITYRETALLYDKEQssflnkervAEVVAHELAHQWFGNLVTMKWWSDLWLNEGFATFAAS--VGVAAVEPT--WQA 386
Cdd:TIGR02411 262 NPNLTFATPTLIAGDRSN---------VDVIAHELAHSWSGNLVTNCSWEHFWLNEGWTVYLERriIGRLYGEKTrhFSA 332
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 387 LSGYA--VNNIlavlnlDALESSHPVSVPIDNPKRI--SEIFDEISYKKGATLIRMM-TMFLGDEVFRKAINRYLLKYSY 461
Cdd:TIGR02411 333 LIGWGdlQESV------KTLGETPEFTKLVVDLKDNdpDDAFSSVPYEKGFNFLFYLeQLLGGPAEFDPFLRHYFKKFAY 406
                         490
                  ....*....|..
gi 1931223940 462 KNAEQDDLWHEL 473
Cdd:TIGR02411 407 KSLDTYQFKDAL 418
M1_APN cd09600
Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the ...
230-459 2.27e-23

Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. It includes bacterial-type alanyl aminopeptidases as well as PfA-M1 aminopeptidase (Plasmodium falciparum-type). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341063 [Multi-domain]  Cd Length: 434  Bit Score: 104.13  E-value: 2.27e-23
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 230 PMSTYLVAFVVSKFSYVESppelSHT-------KFRIWARSDAADQTAYAAnigpRVLTHFEKWFNVSFPLP---KQDMI 299
Cdd:cd09600   174 PKPSYLFALVAGDLGSVED----TFTtksgrkvKLRIYVEPGNEDKCHHAM----ESLKKAMKWDEERFGLEydlDLFNI 245
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 300 -AIPDFSAGAMENWGLITYRETALLYDKEQSSFLNKERVAEVVAHELAHQWFGNLVTMKWWSDLWLNEGFAT-----FAA 373
Cdd:cd09600   246 vAVDDFNMGAMENKGLNIFNSKYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEGLTVfrdqeFSA 325
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 374 SVGVAAVEptwqalsgyavnNILAVLNL-------DALESSHPVsvpidNPKRISEI---FDEISYKKGATLIRMMTMFL 443
Cdd:cd09600   326 DMNSRAVK------------RIEDVRRLrsaqfpeDAGPMAHPI-----RPDSYIEInnfYTVTVYEKGAEVIRMLHTLL 388
                         250
                  ....*....|....*.
gi 1931223940 444 GDEVFRKAINRYLLKY 459
Cdd:cd09600   389 GEEGFRKGMDLYFERH 404
M1_APN_like cd09604
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains ...
237-471 1.46e-19

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains bacterial M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341067 [Multi-domain]  Cd Length: 440  Bit Score: 92.72  E-value: 1.46e-19
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 237 AFVVSK-FSYVESPPelSHTKFRIWARSDAADQTAYAANIGPRVLTHFEKWFnVSFPLPKQDMIAiPDFSAGAMENWGLI 315
Cdd:cd09604   205 AWAASPdFVVDAATV--DGVTVNVYYLPENAEAAERALEYAKDALEFFSEKF-GPYPYPELDVVQ-GPFGGGGMEYPGLV 280
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 316 TYretallydkEQSSFLNKERVAEVVAHELAHQWFGNLVTmkwwSD----LWLNEGFATFAASVGVAAVEPTWQALSGYA 391
Cdd:cd09604   281 FI---------GSRLYDPKRSLEGVVVHEIAHQWFYGIVG----NDerrePWLDEGLATYAESLYLEEKYGKEAADELLG 347
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 392 VNNILAVLNLDALesshPVSVPIDNPKRISEIFDeISYKKGATLIRMMTMFLGDEVFRKAINRYLLKYSYKNAEQDDLWH 471
Cdd:cd09604   348 RRYYRAYARGPGG----PINLPLDTFPDGSYYSN-AVYSKGALFLEELREELGDEAFDKALREYYRRYKFKHPTPEDFFR 422
pepN PRK14015
aminopeptidase N; Provisional
298-521 3.88e-13

aminopeptidase N; Provisional


Pssm-ID: 237585 [Multi-domain]  Cd Length: 875  Bit Score: 73.63  E-value: 3.88e-13
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 298 MI-AIPDFSAGAMENWGL-I---TY----RETALlyDKEqssFLNKERVaevVAHELAHQWFGNLVTMKWWSDLWLNEGF 368
Cdd:PRK14015  256 MIvAVDDFNMGAMENKGLnIfnsKYvladPETAT--DAD---YERIESV---IAHEYFHNWTGNRVTCRDWFQLSLKEGL 327
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 369 -----ATFAASVGVAAVeptwqalsgyavNNILAVLNL-------DALESSHPVsVPidnpkrisEIFDEIS-------Y 429
Cdd:PRK14015  328 tvfrdQEFSADLGSRAV------------KRIEDVRVLraaqfaeDAGPMAHPV-RP--------DSYIEINnfytatvY 386
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 430 KKGATLIRMMTMFLGDEVFRKAINRYLLKYSYKNAEQDDLWHelTMASEShGVlprnvsvktvmD-----TWTTQTGYPL 504
Cdd:PRK14015  387 EKGAEVIRMLHTLLGEEGFRKGMDLYFERHDGQAVTCEDFVA--AMEDAS-GR-----------DlsqfrRWYSQAGTPR 452
                         250       260
                  ....*....|....*....|.
gi 1931223940 505 LTVTRDYDDQS----VTVTQR 521
Cdd:PRK14015  453 VTVSDEYDAAAgtytLTLSQS 473
M1_like_TAF2 cd09839
TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) ...
155-371 7.61e-08

TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) associated factor 2 (TAF2, TBP-associated factor TAFII150, transcription initiation factor TFIID subunit 2, RNA polymerase II TBP-associated factor subunit B), and has homology to the M1 gluzincin family. TAF2 is part of the TFIID multidomain subunit complex essential for transcription of most protein-encoded genes by RNA polymerase II. TAF2 is known to interact with the initiator element (Inr) found at the transcription start site of many genes, thus possibly playing a key role in promoter binding as well as start-site selection. Image analysis has shown TAF2 to form a complex with TAF1 and TBP, inferring its role in promoter recognition. Peptidases in the M1 family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. TAF2, however, lacks these active site residues.


Pssm-ID: 341074 [Multi-domain]  Cd Length: 531  Bit Score: 56.08  E-value: 7.61e-08
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 155 IWARKGFPCFDEPMYKATFKVAI------GHNKDFTAVANMPLMAGTNENAIERHWPWMVI------GQTFNK-DKSSFV 221
Cdd:cd09839   174 GSARCWFPCVDSLWERCTWELEItvprtlGDAGRPPLAGSKEDEDDDDLTEEDKELEMVVVcsgdlvEQVVHPeDPSKKT 253
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 222 WdYFHVSVPMSTYLVAFVVSKFSYVeSPPELSHTKFRIWARSDAADQTAYA-----------ANIGPRVLTHFEKWFNvS 290
Cdd:cd09839   254 F-SFSLSNPTSAQHIGFAVGPFEIV-PLPEFRESEEDDKLGSSAVEVTGFClpgrleelrntCSFLHKAMDFFEEEYG-S 330
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1931223940 291 FPLP--KQ---DMiAIPDFSAGAmenwGLITYrETALLY-----DKEQSsflnkerVAEVVAHELAHQWFGNLVTMKWWS 360
Cdd:cd09839   331 YPFSsyKQvfvDD-LPEDVSSFA----SLSIC-SSRLLYppdiiDQAYE-------TRRKLAHALASQWFGINIIPKTWS 397
                         250
                  ....*....|.
gi 1931223940 361 DLWLNEGFATF 371
Cdd:cd09839   398 DTWLVIGIAGY 408
GluZincin cd09594
Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, ...
340-369 9.64e-06

Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins); The Gluzincin family (thermolysin-like peptidases or TLPs) includes several zinc-dependent metallopeptidases such as M1, M2, M3, M4, M13, M32, M36 peptidases (MEROPS classification), which contain the HEXXH motif as part of their active site. Peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. The M1 family includes aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity such that the two activities occupy different, but overlapping sites. The M3_like peptidases include the M2_ACE, M3 or neurolysin-like family (subfamilies M3B_PepF and M3A) and M32_Taq peptidases. The M2 peptidase angiotensin converting enzyme (ACE, EC 3.4.15.1) catalyzes the conversion of decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. ACE is a key component of the renin-angiotensin system that regulates blood pressure, thus ACE inhibitors are important for the treatment of hypertension. M3A includes thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (3.4.24.16), and the mitochondrial intermediate peptidase; and M3B includes oligopeptidase F. The M32 family includes eukaryotic enzymes from protozoa Trypanosoma cruzi, a causative agent of Chagas' disease, and from Leishmania major, a parasite that causes leishmaniasis, making these enzymes attractive targets for drug development. The M4 family includes secreted protease thermolysin (EC 3.4.24.27), pseudolysin, aureolysin, and neutral protease as well as bacillolysin (EC 3.4.24.28) that degrade extracellular proteins and peptides for bacterial nutrition, especially prior to sporulation. Thermolysin is widely used as a nonspecific protease to obtain fragments for peptide sequencing as well as in production of the artificial sweetener aspartame. The M13 family includes neprilysin (EC 3.4.24.11) and endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad range of physiological roles due to the greater variation in the S2' subsite allowing substrate specificity and are prime therapeutic targets for selective inhibition. The peptidase M36 fungalysin family includes endopeptidases from pathogenic fungi. Fungalysin hydrolyzes extracellular matrix proteins such as elastin and keratin. Aspergillus fumigatus causes the pulmonary disease aspergillosis by invading the lungs of immuno-compromised animals and secreting fungalysin that possibly breaks down proteinaceous structural barriers.


Pssm-ID: 341057 [Multi-domain]  Cd Length: 105  Bit Score: 45.17  E-value: 9.64e-06
                          10        20        30
                  ....*....|....*....|....*....|.
gi 1931223940 340 VVAHELAHQWFGNLVTMKW-WSDLWLNEGFA 369
Cdd:cd09594    68 VLAHELTHAFTGQFSNLMYsWSSGWLNEGIS 98
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH